Skip to main content
KOREA PHARMA Co., Ltd. logo

KOREA PHARMA Co., Ltd. — Investor Relations & Filings

Ticker · 032300 ISIN · KR7032300006 KO Manufacturing
Open in API
Filings indexed 177 across all filing types
Latest filing 2022-01-03 Regulatory Filings
Country KR South Korea
Listing KO 032300

About KOREA PHARMA Co., Ltd.

https://www.koreapharma.co.kr/eng/main/…

KOREA PHARMA Co., Ltd. is a pharmaceutical company established in 1974 that specializes in the development and production of prescription-based medicines. The company has a particular focus on drugs for the Central Nervous System (CNS). Its product portfolio covers a wide range of therapeutic areas, including hepatic, gastrointestinal, antimicrobial, and antihistamine drugs. The company also offers treatments such as amino acids, antibiotics, antidotes, and antiepileptics, aiming to improve and maintain public health through its specialized pharmaceutical products.

Recent filings

Filing Released Lang Actions
투자판단관련주요경영사항(노인 근감소증 환자에서 KP203 반복 투여의 유효성 및 안전성 평가를 위한 다기관, 용량 탐색, 제2상 임상시험계획 신청)
Regulatory Filings Classification · 100% confidence The document is a regulatory filing from a Korean company (한국파마) regarding a 'Major Management Matter' (주요경영사항), specifically the submission of a Phase 2 clinical trial application (IND) to the Ministry of Food and Drug Safety (MFDS). Since this is a formal regulatory disclosure of a material business event that does not fit into specific categories like financial reports or dividend notices, it falls under the general regulatory filing category.
2022-01-03 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Financial Supervisory Service in South Korea. This type of filing is specifically used to report insider trading activities (share disposals by an executive, Lee Chan-bok). According to the provided definitions, reports of personal share transactions by company directors and executives are classified as 'Director's Dealing'.
2021-12-30 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is titled '임원ㆍ주요주주 특정증권등 소유상황보고서' (Report on Ownership of Specific Securities by Executives and Major Shareholders). This is a standard regulatory filing in South Korea (often referred to as a 'Section 16' equivalent in the US) where company insiders report changes in their shareholdings. Based on the provided definitions, this falls under 'Director's Dealing' (DIRS), which covers personal share transactions by company directors and executives.
2021-12-30 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is titled '임원ㆍ주요주주 특정증권등 소유상황보고서' (Report on Ownership of Specific Securities by Executives and Major Shareholders). It details the change in share ownership by a specific individual (Park Shin Ung) due to his resignation as an executive. This type of filing is a standard regulatory requirement for insider trading or changes in executive holdings, which corresponds to the 'Director's Dealing' category.
2021-12-23 Korean
주주명부폐쇄기간또는기준일설정
Regulatory Filings Classification · 95% confidence The document is a short regulatory announcement regarding the setting of a record date and shareholder register closure for the purpose of holding an Annual General Meeting. It does not contain the full report or proxy materials themselves, but rather serves as a formal notification of the upcoming meeting logistics. Given the nature of the announcement as a regulatory disclosure, it fits best under the RNS category.
2021-12-13 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding of Stocks, etc.), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details changes in share ownership by major shareholders and special related parties, including specific transaction dates, methods (e.g., '장내매도' - open market sale), and collateral agreements. This falls under the category of Major Shareholding Notification (MRQ) as it tracks significant ownership changes and threshold reporting.
2021-11-25 Korean

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.